Parenteral Drugs (India) is currently trading at Rs. 56.55, up by 9.40 points or 19.94 % from its previous closing of Rs. 47.15 on the BSE.
The scrip opened at Rs. 48.10 and has touched a high and low of Rs. 56.55 and Rs. 48.00 respectively. So far 277673 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 54.45 on 20-Oct-2015 and a 52 week low of Rs. 16.30 on 27-Mar-2015.
Last one week high and low of the scrip stood at Rs. 49.00 and Rs. 43.00 respectively. The current market cap of the company is Rs. 168.61 crore.
The promoters holding in the company stood at 73.28 % while Institutions and Non-Institutions held 0.03 % and 26.69 % respectively.
Parenteral Drugs India has received an approval for disinvestment of equity shares held by the company in its non-operational subsidiary companies. The board of directors at their meeting held on December 30, 2015 has approved for the same.
The company has received approval for disinvestment of equity shares held in Parentech Healthcare and Parenteral Surgicals as the same are loss making companies, and accorded its in-principle approval to declare the non-working subsidiaries of the company - Abhay Drugs, Anjaney Pharmaceuticals, Parenteral Biotech and Parenteral Impex as defunct company as there is no business in these subsidiary companies.
Parenteral Drugs (India) (PDIL) is a manufacturer of Intravenous Fluid (IVF), one of the basic pharmaceutical compounds.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1811.80 |
Dr. Reddys Lab | 1353.00 |
Cipla | 1475.15 |
Lupin | 2155.60 |
Zydus Lifesciences | 973.30 |
View more.. |